Cite
MLA Citation
O Hamid et al.. “Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.” Annals of oncology, vol. 30, 2019, pp. 582–588. http://access.bl.uk/ark:/81055/vdc_100092354073.0x00002f